These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6892781)

  • 1. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
    Charachon R; Lavillauroy PJ; Fumex JP
    Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP; Michel FB
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB; Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
    Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP
    Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the chronic toxicity of D 53 by aerosol. One-year observation.
    Fontanges R; Robert D; Isoard P
    Arzneimittelforschung; 1980; 30(1a):187-96. PubMed ID: 6989375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomodulatory properties of ribosomal vaccine in the prevention of recurrent infections].
    Gawlik R; Danek K
    Przegl Lek; 2002; 59(6):450-2. PubMed ID: 12418285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of bacterial respiratory infections by ribosomal vaccines].
    Michel FB; D'Hinterland LD; Fumex JP; Guendon R
    Bronchopneumologie; 1979; 29(4):337-42. PubMed ID: 509335
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine.
    Faure GC; Béné MC; Simon C; Quantain A
    Int J Immunopharmacol; 1990; 12(3):315-20. PubMed ID: 2184137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S; Tazza R
    Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterial polysaccharide-protein conjugate vaccines.
    Finn A
    Br Med Bull; 2004; 70():1-14. PubMed ID: 15339854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunization in pneumology].
    Schaberg T; Lode H
    Pneumologie; 1994 Aug; 48(8):505-10. PubMed ID: 7971886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic bronchopulmonary infections].
    Popescu C; Meitert E; Russ R; Meitert T; Sima F; Savulian C; Esrig E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):261-72. PubMed ID: 6318298
    [No Abstract]   [Full Text] [Related]  

  • 15. [What to expect from vaccine prevention in acute respiratory tract infection in children?].
    Gaudelus J
    Rev Prat; 2007 Nov; 57(17):1912-8. PubMed ID: 18095628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of a polyvalent bacterial vaccine administered by aerosol in the treatment of children with respiratory infections].
    Vascotto M; Fossi E; Mancini E; Guerrini L
    Minerva Pediatr; 1985 May; 37(10):409-14. PubMed ID: 4047012
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recurrent respiratory diseases in young children and the value of nonspecific immunostimulation in the prevention and treatment of such diseases].
    Herzovi F
    Rev Pediatr Obstet Ginecol Pediatr; 1978; 27(3):245-8. PubMed ID: 103162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a polyvalent oral bacterial vaccine in recurrent respiratory infections in children].
    Scotti L; Biondelli G; Borzani M
    Minerva Pediatr; 1987 Apr; 39(7):251-6. PubMed ID: 3614148
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccinology in the prophylaxis of respiratory infections--Part II.
    Griffin JP
    Clin Notes Respir Dis; 1978; 17(2):3-12. PubMed ID: 699411
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective measures against acute respiratory symptoms in French pilgrims participating in the Hajj of 2009.
    Gautret P; Vu Hai V; Sani S; Doutchi M; Parola P; Brouqui P
    J Travel Med; 2011; 18(1):53-5. PubMed ID: 21199143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.